Ftse Mib
33.834,91
0,00%
DAX
18.342,83
0,00%
S&P 500
5.447,87
-0,31%
NASDAQ
17.496,82
-1,09%
Bitcoin
61.102,47
1,39%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Aim Immunotech Inc (0A4Y) Aim Immunotech Inc (0A4Y) Notizie

Aim Immunotech Inc

0A4Y
0,00
0,00 (0,00%)
- - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/5/202414:50UKREGAIM ImmunoTech to Discuss First Quarter 2024 Financial..
06/5/202414:30UKREGAIM ImmunoTech Completes cGMP Manufacturing of Clinical..
29/4/202414:55UKREGAIM ImmunoTech Announces First Dose Level is Generally..
10/4/202414:21UKREGAIM ImmunoTech Announces Positive Top-Line, Protocol-Planned..
02/4/202413:30UKREGAIM ImmunoTech Reports Fourth Quarter and Full Year 2023..
26/3/202414:05UKREGAIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023..
25/3/202414:05UKREGAIM ImmunoTech Announces Publication of Positive Findings..
07/3/202414:45UKREGAIM ImmunoTech Announces Launch of CEO Corner Platform
29/2/202414:45UKREGAIM ImmunoTech Outlines Recent Progress Across Clinical..
14/2/202414:55UKREGAIM ImmunoTech Announces First Subject Dosed in the..
24/1/202415:10GLOBEAIM ImmunoTech Receives Erasmus Medical Center Ethics Board..
22/1/202414:55GLOBEAIM ImmunoTech Announces that the First Subject is Enrolled..
10/1/202414:45GLOBEAIM ImmunoTech Announces Open Enrollment for Phase 1b/2..
27/11/202315:05GLOBEAIM ImmunoTech Bolsters Intellectual Property Estate for..
15/11/202313:30GLOBEAIM ImmunoTech Reports Third Quarter 2023 Financial Results..
09/11/202314:05GLOBEAIM ImmunoTech to Discuss Third Quarter 2023 Financial..
17/10/202314:45GLOBEAIM ImmunoTech Engages Business Development Firm, Azenova,..
11/9/202319:00GLOBEAIM ImmunoTech Announces Report of Complete Topline Data..
15/8/202312:45GLOBEAIM ImmunoTech Reports Second Quarter Financial Results and..
09/8/202315:05GLOBEAIM ImmunoTech to Discuss Second Quarter 2023 Financial..
08/8/202314:05GLOBEAIM ImmunoTech Announces Completion of Enrollment in Phase 2..
19/7/202301:30GLOBEAIM ImmunoTech Issues Notice that an Unaffiliated Third..
10/7/202314:05GLOBEAIM ImmunoTech Enrolls and Doses First Subject in Phase 2..
27/6/202317:16GLOBEAIM ImmunoTech Announces Publication of Positive Findings..
27/6/202314:45GLOBEAIM ImmunoTech Announces Authorizations from Competent..
Apertura: Min: Max:
Chiusura:

La tua Cronologia

LSE
0A4Y
Aim Immunotech
AQEU
ORP
LOreal
USOTC
KBRLF
K Bro Linen (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network